Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2025 04:17 ET | Source: Research and Markets

Perjeta (Pertuzumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2034

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Perjeta (Pertuzumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's...
January 30, 2024 06:43 ET | Source: Research and Markets

Triple Negative Breast Cancer Epidemiology Forecast to 2032: Highlights Emerging Trends and Patient Pool Growth in Key Regions

Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Triple Negative Breast Cancer - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Industry experts have...
January 24, 2024 10:35 ET | Source: Research and Markets

HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
April 07, 2023 07:03 ET | Source: Research and Markets

HER2 Inhibitors Global Market Report 2023: Featuring F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Boehringer-Ingelheim, Mylan & Biocon

Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global her2 inhibitors market is expected...
October 22, 2021 04:53 ET | Source: Research and Markets

Global Herceptin (Trastuzumab) Biosimilars Pipeline Guide 2021

Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...